Other OTC - Delayed Quote • USD
ARYx Therapeutics, Inc. (ARYX)
At close: February 29 at 12:20 PM EST
Breakdown
TTM
Operating Expense
16,727.0000
Operating Income
-16,727.0000
Net Non Operating Interest Income Expense
-1,615.0000
Net Income Common Stockholders
-18,328.0000
Diluted NI Available to Com Stockholders
-18,328.0000
Basic EPS
-0.60
Diluted EPS
-0.60
Basic Average Shares
30,963.7500
Diluted Average Shares
30,963.7500
Total Operating Income as Reported
-16,727.0000
Total Expenses
16,727.0000
Net Income from Continuing & Discontinued Operation
-18,328.0000
Normalized Income
-18,337.1000
Interest Income
76.0000
Interest Expense
1,691.0000
Net Interest Income
-1,615.0000
EBIT
-16,727.0000
EBITDA
-15,778.0000
Reconciled Depreciation
949.0000
Net Income from Continuing Operation Net Minority Interest
-18,328.0000
Total Unusual Items Excluding Goodwill
14.0000
Total Unusual Items
14.0000
Normalized EBITDA
-15,792.0000
Tax Rate for Calcs
0.0004
Tax Effect of Unusual Items
4.9000
-
Yahoo Finance Plus Essential access required. Unlock Access